We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Automated, POC Disinfectant System Helps Combat COVID-19 and Healthcare Associated Pathogens

By HospiMedica International staff writers
Posted on 10 Jan 2022

An automated, point of care disinfectant system can help improve the safety of healthcare workers and patients by reducing exposure to COVID-19 and other healthcare associated pathogens. More...

Sterifre Medical, Inc. (Kirkland, Wash., USA) has been granted by the U.S. Environmental Protection Agency (EPA) to begin commercial deployment of AURA, the company's novel, automated device disinfectant system. AURA system is believed to be the first registered, automated, point-of-care solution providing fast disinfection for non-critical medical devices and common articles used in the healthcare environment. It replaces the need for cumbersome and often challenging manual disinfection with wipes, reducing exposure of health care workers and patients alike to pathogens that cause healthcare associated infections (HAI).

Research finds up to 97% of common healthcare equipment may be contaminated with multiple organisms. The AURA system utilizes a patented application of hydrogen peroxide and activated oxygen to inactivate microorganisms that cause disease. It also significantly reduces the amount of time spent on manual disinfection, is more cost effective than current methods, and can improve the quality of direct patient care. The AURA disinfection system plugs in to a standard electrical outlet in any hospital or clinic patient care area, taking up about the same counterspace as a laptop computer.

As a regulator for microbicides used for hospital disinfection, the EPA's registration for Sterifre recognizes the company conducted extensive microbial testing using EPA approved protocols at a laboratory under industry standard "Good Lab Practice (GLP)". Sterifre also meets the EPA approval requirements under the Emerging Viral Pathogens Program for inactivating SARS-CoV-2, the coronavirus that causes COVID-19, because the AURA system has demonstrated effectiveness against viruses similar to SARS-CoV-2.

The AURA technology uses a well-recognized disinfectant that is consumed in the process, leaving no residual disinfectant. Since the only byproduct of AURA is clean air, it can be used anywhere there is an electrical outlet. The system continuously monitors treatment parameters and automatically indicates when disinfection is completed.

"Our first-of-its kind AURA system was designed to address many of the challenges that healthcare facilities face today. Sterifre is committed to putting fully validated, approved, state-of-the-art tools in the hands of healthcare workers," said Mike Goonewardene, chief commercial officer at Sterifre.

"The EPA is very focused on providing access to innovative solutions like our AURA disinfection system. Our approval and subsequent filings are for a broad set of efficacy claims." explained Richard Shea, chief executive officer at Sterifre.

Related Links:
Sterifre Medical, Inc. 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Tourniquet System
heidi– mein Tourniquet
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The three-dimensional scan is divided into a series of two-dimensional images, which are then broken down into smaller sections along the tissue surface. The AI algorithm assesses for each of these sections how much the tissue differs from healthy tissue (Photo courtesy of Fraunhofer Austria)

Rapid AI OCT System Detects Malignant Liver Tissue Intraoperatively

Liver cancer commonly requires resection, yet confirming complete tumor removal relies on frozen-section analysis that prolongs anesthesia and ties up operating rooms. Longer cases increase risks for bleeding,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.